getting FDA clearance(once its complicated ). is bit tough , they pointed out lapses in quality and some irregularities in records , we must see how long it takes Meanwhile better to be distant to this stock.Even the process itself is time consuming..
about 2 hrs 15 min 27 sec ago
of the demonetisation and currency shortfall affecting retail trade off takes. My guess overall - Q3 shud be similar to Q2 or slightly better in overall earnings. Q4 shud be a blockbuster. Let`s see how it unfolds For the upcoming week - all eyes and ears will be on the Kothur FDA outcome and TAD update on Mylan`s g
12.13 PM Jan 21st
by the demonetisation and the recent fall in rupee against the dollar could very well provide a positive impact on their cash flow and q3 results. coral labs is exporting their procuts in the developing and under developed countries where the fda issue is not bitng the pharma company.
12.38 PM Jan 20th
and what will be an important milestone to achieve. My guess is that (on approval) Mylan/Natco will launch the 20 mg but will be cautious before deciding in launching the 40 mg. All said, the approvals need to come from the FDA which will provide a good indication for the next things that can follow
12.45 PM Jan 19th
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.